WO1998029436A3 - Peptides de lebetine utilises comme inhibiteurs de l'agregation plaquettaire - Google Patents

Peptides de lebetine utilises comme inhibiteurs de l'agregation plaquettaire Download PDF

Info

Publication number
WO1998029436A3
WO1998029436A3 PCT/EP1997/007335 EP9707335W WO9829436A3 WO 1998029436 A3 WO1998029436 A3 WO 1998029436A3 EP 9707335 W EP9707335 W EP 9707335W WO 9829436 A3 WO9829436 A3 WO 9829436A3
Authority
WO
WIPO (PCT)
Prior art keywords
lebetin
peptides
platelet aggregation
aggregation inhibitors
amino acid
Prior art date
Application number
PCT/EP1997/007335
Other languages
English (en)
Other versions
WO1998029436A2 (fr
Inventor
Herve Rochat
Kamel Mabrouk
Mohammed El-Ayeb
Original Assignee
Armel Sa
Herve Rochat
Kamel Mabrouk
El Ayeb Mohammed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armel Sa, Herve Rochat, Kamel Mabrouk, El Ayeb Mohammed filed Critical Armel Sa
Priority to CA002275544A priority Critical patent/CA2275544A1/fr
Priority to AU58612/98A priority patent/AU5861298A/en
Publication of WO1998029436A2 publication Critical patent/WO1998029436A2/fr
Publication of WO1998029436A3 publication Critical patent/WO1998029436A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des peptides de lebetine qui présentent la séquence d'acides aminés (X)mNKPPKKGPPNG(CFGHKIDRIGSHSGLGCNKVDDNKG)n(X)p où m = 0 à 6, n = 0 ou 1, p = 0 à 4 et chaque X est un résidu d'acide aminé. Ces peptides sont des agents efficaces pour inhiber l'agrégation plaquettaire, et peuvent également être utiles pour traiter les thromboses ou les thrombo-embolies.
PCT/EP1997/007335 1996-12-31 1997-12-30 Peptides de lebetine utilises comme inhibiteurs de l'agregation plaquettaire WO1998029436A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002275544A CA2275544A1 (fr) 1996-12-31 1997-12-30 Peptides de lebetine utilises comme inhibiteurs de l'agregation plaquettaire
AU58612/98A AU5861298A (en) 1996-12-31 1997-12-30 Lebetin peptides as platelet aggregation inhibitors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9627116.8A GB9627116D0 (en) 1996-12-31 1996-12-31 Lebetin peptides as platelet aggregation inhibitors
GB9627116.8 1996-12-31

Publications (2)

Publication Number Publication Date
WO1998029436A2 WO1998029436A2 (fr) 1998-07-09
WO1998029436A3 true WO1998029436A3 (fr) 1998-09-03

Family

ID=10805141

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/007335 WO1998029436A2 (fr) 1996-12-31 1997-12-30 Peptides de lebetine utilises comme inhibiteurs de l'agregation plaquettaire

Country Status (4)

Country Link
AU (1) AU5861298A (fr)
CA (1) CA2275544A1 (fr)
GB (1) GB9627116D0 (fr)
WO (1) WO1998029436A2 (fr)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
R BARBOUCHE ET AL.: "Novel anti-platelet aggregation polypeptides from Vipera lebetina venom; isolation and characterization", FEBS LETTERS., vol. 392, no. 1, 19 August 1996 (1996-08-19), AMSTERDAM NL, pages 6 - 10, XP002066590 *

Also Published As

Publication number Publication date
AU5861298A (en) 1998-07-31
CA2275544A1 (fr) 1998-07-09
WO1998029436A2 (fr) 1998-07-09
GB9627116D0 (en) 1997-02-19

Similar Documents

Publication Publication Date Title
MY116539A (en) New amino acid derivatives
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
GR3023233T3 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
FI955315A0 (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
TR200202323T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
DE69728594D1 (de) Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen
SE9602263D0 (sv) New amino acid derivatives
SE9602646D0 (sv) Pharmaceutically-useful compounds
AU4064597A (en) Amidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereof
AU5327286A (en) Peptide derivatives which inhibit renin and acid proteases
HK1018742A1 (en) Preparation containing a combination of 5-methylisoxazole-4-carboxyclic acid-(4-triflouromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
EP0310072A3 (fr) Bêta-succinamidoacyl aminodiols non peptidiques comme agents anti-hypertensifs
BG102814A (en) New derivatives of carboxylic acid, their preparation and application
WO1994000555A3 (fr) Compositions d'inhibition de la formation d'hormones proteiniques et leurs utilisations
AU3496295A (en) 2-substituted-4h-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement clr protease for the treatment of inflammatory processes
FI935780A (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
GB9515802D0 (en) Hiv protease inhibitors useful for the treatment of aids
WO1998029436A3 (fr) Peptides de lebetine utilises comme inhibiteurs de l'agregation plaquettaire
IL130642A0 (en) N-(pyridinylamino)isoindolines and related compounds
TW340108B (en) 1,1-difluoro-1,4-dichlorobutane and process for its preparation
EP0912170A4 (fr) Inhibiteurs de la protease du vih utiles dans le traitement du sida
CA2183320A1 (fr) Nouveaux derives bisulfure de mercaptoacetylamides utiles comme inhibiteurs de l'enkephalinase et de l'enzyme de conversion de l'angiotensine (ace)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2275544

Country of ref document: CA

Ref country code: CA

Ref document number: 2275544

Kind code of ref document: A

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase